R&D
A Cancer Cell Therapy Put Severe Rheumatoid Arthritis Into Remission
CD19 CAR-T — built to fight blood cancers — drove treatment-refractory rheumatoid arthritis into remission in a small study, with some patients drug-free for up to a year.